Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM50246809 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1676839 (CHEMBL4026982) | ||
IC50 | 3.0±n/a nM | ||
Citation | Scott, JS; Degorce, SL; Anjum, R; Culshaw, J; Davies, RDM; Davies, NL; Dillman, KS; Dowling, JE; Drew, L; Ferguson, AD; Groombridge, SD; Halsall, CT; Hudson, JA; Lamont, S; Lindsay, NA; Marden, SK; Mayo, MF; Pease, JE; Perkins, DR; Pink, JH; Robb, GR; Rosen, A; Shen, M; McWhirter, C; Wu, D Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88 J Med Chem60:10071-10091 (2017) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM50246809 | |||
n/a | |||
Name | BDBM50246809 | ||
Synonyms: | CHEMBL4104802 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H37N7O2 | ||
Mol. Mass. | 455.5963 | ||
SMILES | CN(C)C(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)Nc1ncnc2[nH]cc(C3CCOCC3)c12 |r,wU:14.18,wD:11.11,(20.28,-15.59,;20.29,-14.05,;21.63,-13.29,;18.96,-13.27,;18.97,-11.73,;17.62,-14.03,;17.61,-15.57,;16.28,-16.33,;14.96,-15.55,;14.95,-14.01,;16.3,-13.25,;13.62,-16.32,;12.29,-15.54,;10.95,-16.31,;10.96,-17.85,;12.29,-18.62,;13.62,-17.86,;9.63,-18.62,;9.63,-20.16,;10.96,-20.92,;10.97,-22.47,;9.63,-23.24,;8.3,-22.47,;6.83,-22.96,;5.92,-21.72,;6.82,-20.46,;6.33,-19,;7.35,-17.85,;6.87,-16.39,;5.36,-16.07,;4.34,-17.22,;4.82,-18.69,;8.29,-20.93,)| | ||
Structure |